Avidity Partners Management as of Dec. 31, 2023
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 73 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Arvinas Ord (ARVN) | 4.5 | $123M | 3.0M | 41.16 | |
Boston Scientific Corporation (BSX) | 4.0 | $109M | 1.9M | 57.81 | |
Cigna Corp Call Option (CI) | 3.8 | $105M | 350k | 299.45 | |
Thermo Fisher Scientific (TMO) | 3.5 | $97M | 183k | 530.79 | |
Acadia Healthcare (ACHC) | 3.3 | $90M | 1.2M | 77.76 | |
Neurocrine Biosciences (NBIX) | 3.2 | $87M | 658k | 131.76 | |
Syndax Pharmaceuticals (SNDX) | 3.1 | $85M | 4.0M | 21.61 | |
Natera (NTRA) | 2.5 | $70M | 1.1M | 62.64 | |
Structure Therapeutics Sponsored Ads (GPCR) | 2.5 | $69M | 1.7M | 40.76 | |
Danaher Corporation (DHR) | 2.4 | $67M | 290k | 231.34 | |
Tenet Healthcare Corp Com New (THC) | 2.4 | $66M | 871k | 75.57 | |
Karuna Therapeutics Ord | 2.4 | $65M | 206k | 316.51 | |
Fusion Pharmaceuticals (FUSN) | 2.3 | $63M | 6.5M | 9.61 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.2 | $60M | 489k | 123.00 | |
Regeneron Pharmaceuticals (REGN) | 2.2 | $60M | 68k | 878.29 | |
CVS Caremark Corporation (CVS) | 2.1 | $58M | 740k | 78.96 | |
Blueprint Medicines (BPMC) | 2.1 | $57M | 615k | 92.24 | |
ImmunoGen | 2.0 | $54M | 1.8M | 29.65 | |
Ideaya Biosciences (IDYA) | 2.0 | $54M | 1.5M | 35.58 | |
United Therapeutics Corporation (UTHR) | 1.9 | $52M | 237k | 219.89 | |
Rocket Pharmaceuticals (RCKT) | 1.9 | $52M | 1.7M | 29.97 | |
Intra Cellular Therapies (ITCI) | 1.9 | $51M | 710k | 71.62 | |
Eli Lilly & Co. (LLY) | 1.8 | $50M | 85k | 582.92 | |
Biohaven (BHVN) | 1.8 | $49M | 1.1M | 42.80 | |
Avantor (AVTR) | 1.8 | $48M | 2.1M | 22.83 | |
Zoetis Cl A (ZTS) | 1.7 | $47M | 240k | 197.37 | |
Humana (HUM) | 1.7 | $46M | 100k | 457.81 | |
Abbvie (ABBV) | 1.6 | $44M | 284k | 154.97 | |
Align Technology (ALGN) | 1.6 | $43M | 156k | 274.00 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 1.5 | $41M | 685k | 60.17 | |
Becton, Dickinson and (BDX) | 1.5 | $40M | 166k | 243.83 | |
Ultragenyx Pharmaceutical (RARE) | 1.5 | $40M | 845k | 47.82 | |
McKesson Corporation (MCK) | 1.4 | $40M | 86k | 462.98 | |
Xenon Pharmaceuticals (XENE) | 1.4 | $38M | 816k | 46.06 | |
Surgery Partners (SGRY) | 1.4 | $37M | 1.2M | 31.99 | |
Axsome Therapeutics (AXSM) | 1.3 | $37M | 459k | 79.59 | |
Caribou Biosciences (CRBU) | 1.3 | $36M | 6.4M | 5.73 | |
Vaxcyte (PCVX) | 1.3 | $36M | 570k | 62.80 | |
Neumora Therapeutics (NMRA) | 1.2 | $34M | 2.0M | 17.05 | |
Mirum Pharmaceuticals (MIRM) | 1.2 | $34M | 1.1M | 29.52 | |
UnitedHealth (UNH) | 1.1 | $31M | 59k | 526.47 | |
Privia Health Group (PRVA) | 1.1 | $30M | 1.3M | 23.03 | |
Intuitive Surgical Com New (ISRG) | 1.0 | $29M | 85k | 337.36 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.9 | $24M | 380k | 62.00 | |
An2 Therapeutics (ANTX) | 0.9 | $23M | 1.1M | 20.49 | |
Ac Immune Sa SHS (ACIU) | 0.8 | $22M | 4.5M | 5.00 | |
Arrowhead Pharmaceuticals (ARWR) | 0.8 | $22M | 714k | 30.60 | |
Immunocore Hldgs Ads (IMCR) | 0.7 | $21M | 300k | 68.32 | |
Crinetics Pharmaceuticals In (CRNX) | 0.7 | $19M | 529k | 35.58 | |
Phathom Pharmaceuticals (PHAT) | 0.6 | $16M | 1.7M | 9.13 | |
Verona Pharma Sponsored Ads (VRNA) | 0.6 | $16M | 781k | 19.88 | |
Immunome (IMNM) | 0.5 | $14M | 1.3M | 10.70 | |
Agilent Technologies Inc C ommon (A) | 0.5 | $14M | 99k | 139.03 | |
Intellia Therapeutics (NTLA) | 0.5 | $14M | 447k | 30.49 | |
Syros Pharmaceuticals Com New (SYRS) | 0.5 | $13M | 1.7M | 7.79 | |
Dianthus Therapeutics (DNTH) | 0.5 | $13M | 1.2M | 10.40 | |
Argenx Se Sponsored Adr (ARGX) | 0.4 | $12M | 31k | 380.43 | |
Cerevel Therapeutics Hldng I (CERE) | 0.4 | $12M | 277k | 42.40 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.4 | $11M | 361k | 30.78 | |
Immunovant (IMVT) | 0.4 | $10M | 245k | 42.13 | |
Neurogene (NGNE) | 0.3 | $9.0M | 466k | 19.38 | |
Travere Therapeutics (TVTX) | 0.3 | $7.4M | 827k | 8.99 | |
Karyopharm Therapeutics (KPTI) | 0.3 | $7.2M | 8.3M | 0.86 | |
Akero Therapeutics (AKRO) | 0.2 | $5.5M | 235k | 23.35 | |
Kezar Life Sciences (KZR) | 0.2 | $4.8M | 5.0M | 0.95 | |
Century Therapeutics (IPSC) | 0.2 | $4.5M | 1.4M | 3.32 | |
Scynexis Com New (SCYX) | 0.1 | $3.2M | 1.4M | 2.23 | |
Compass Therapeutics (CMPX) | 0.1 | $2.5M | 1.6M | 1.56 | |
Revolution Medicines (RVMD) | 0.1 | $1.7M | 60k | 28.68 | |
Hyperfine Com Cl A (HYPR) | 0.0 | $1.3M | 1.2M | 1.12 | |
Amylyx Pharmaceuticals (AMLX) | 0.0 | $950k | 65k | 14.72 | |
Caremax Com Cl A | 0.0 | $317k | 636k | 0.50 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $5.4k | 90k | 0.06 |